These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21729901)

  • 1. COPD and lung cancer linked at a molecular genetic level.
    Young RP; Hopkins RJ
    Chest; 2011 Jul; 140(1):266-267. PubMed ID: 21729901
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics of lung cancer susceptibility and COPD.
    Young R; Hopkins R; Etzel C; El-Zein R
    Lancet Oncol; 2011 Jul; 12(7):622-3. PubMed ID: 21708349
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk.
    El-Zein RA; Young RP; Hopkins RJ; Etzel CJ
    Cancer Prev Res (Phila); 2012 Apr; 5(4):522-7. PubMed ID: 22491518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD and lung cancer have come a long way ...baby.
    Mannino DM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):108-9. PubMed ID: 17617532
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.
    Schwartz AG; Ruckdeschel JC
    Am J Respir Crit Care Med; 2006 Jan; 173(1):16-22. PubMed ID: 16141445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic dependences between lung cancer and chronic obstructive pulmonary disease.
    Grudny J; Kołakowski J; Kruszewski M; Szopiński J; Sliwiński P; Wiatr E; Winek J; Załęska J; Zych J; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2013; 81(4):308-18. PubMed ID: 23744166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
    Brzóska K; Bartłomiejczyk T; Sochanowicz B; Cymerman M; Grudny J; Kołakowski J; Kapka-Skrzypczak L; Kruszewski M; Sliwiński P; Roszkowski-Śliż K
    Ann Agric Environ Med; 2014; 21(3):546-51. PubMed ID: 25292126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
    PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea.
    Kim WJ; Oh YM; Kim TH; Lee JH; Kim EK; Lee JH; Lee SM; Shin TR; Yoon HI; Lim SY; Lee SD
    Respiration; 2013; 86(2):117-22. PubMed ID: 23207642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer - a comorbidity in chronic obstructive pulmonary disease.
    Roca M; Roca IC; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1055-62. PubMed ID: 23700888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How the genetics of lung cancer may overlap with COPD.
    Young RP; Hopkins RJ
    Respirology; 2011 Oct; 16(7):1047-55. PubMed ID: 21749550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic acetylcholine receptors and predisposition to lung cancer.
    Tournier JM; Birembaut P
    Curr Opin Oncol; 2011 Jan; 23(1):83-7. PubMed ID: 21045689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer gene associated with COPD: triple whammy or possible confounding effect?
    Young RP; Hopkins RJ; Hay BA; Epton MJ; Black PN; Gamble GD
    Eur Respir J; 2008 Nov; 32(5):1158-64. PubMed ID: 18978134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases.
    Ziółkowska-Suchanek I; Mosor M; Gabryel P; Grabicki M; Żurawek M; Fichna M; Strauss E; Batura-Gabryel H; Dyszkiewicz W; Nowak J
    Sci Rep; 2015 Aug; 5():13502. PubMed ID: 26310313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients.
    Wojas-Krawczyk K; Krawczyk P; Biernacka B; Grzybek M; Kołodziej P; Kucharczyk T; Mlak R; Milanowski J
    Eur J Cancer Prev; 2012 Mar; 21(2):111-7. PubMed ID: 21955800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
    Hu H; Zhang L; Teng G; Wu Y; Chen Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COPD, lung cancer--a common molecular pathway?].
    Jassem E
    Pneumonol Alergol Pol; 2013; 81(4):283-4. PubMed ID: 23885388
    [No Abstract]   [Full Text] [Related]  

  • 18. [COPD and lung cancer: epidemiological and biological links].
    Prevot G; Plat G; Mazieres J
    Rev Mal Respir; 2012 Apr; 29(4):545-56. PubMed ID: 22542412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
    Xu PW; Jin YT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.
    Tessema M; Yingling CM; Picchi MA; Wu G; Liu Y; Weissfeld JL; Siegfried JM; Tesfaigzi Y; Belinsky SA
    J Thorac Oncol; 2015 Aug; 10(8):1181-8. PubMed ID: 26200272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.